Effects of structured care by a pharmacist-diabetes specialist team in patients with Type 2 diabetic nephropathy Wilson Y.S. Leung, BPharm, PhD, Wing-Yee So, MBChB, MRCP, Peter C.Y. Tong, PhD, Norman N. Chan, MD, Juliana C.N. Chan, MD The American Journal of Medicine Volume 118, Issue 12, Pages 1414.e21-1414.e27 (December 2005) DOI: 10.1016/j.amjmed.2005.07.050 Copyright © 2005 Elsevier Inc. Terms and Conditions
Figure 1 Kaplan-Meier curves for the primary composite endpoint of end-stage renal disease or all-cause death (A), end-stage renal disease (B), and all-cause death (C). The American Journal of Medicine 2005 118, 1414.e21-1414.e27DOI: (10.1016/j.amjmed.2005.07.050) Copyright © 2005 Elsevier Inc. Terms and Conditions